Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
04/2007
04/18/2007EP1773326A2 Mitotic kinesin inhibitors
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007CN1949966A Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof
04/18/2007CN1948314A 8-arylamine-3H-imidazole [4,5-g] quinazoline derivatives and its solid phase synthesis method
04/18/2007CN1310905C Antivirally active heterocyclic azahexane derivatives
04/17/2007US7205305 Inhibitors of p38
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders
04/17/2007US7205300 Aryl fused azapolycyclic compounds
04/17/2007US7205298 Substituted triazine kinase inhibitors
04/17/2007CA2269589C A solid-phase technology for the preparation of amides
04/17/2007CA2203592C Process for the preparation of arylamides of heteroaromatic carboxylic acids
04/17/2007CA2106882C Azaquinoxalines, processes for their preparation and their use
04/12/2007WO2007041366A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/12/2007WO2007041365A2 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
04/12/2007WO2007041077A2 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
04/12/2007WO2007041023A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
04/12/2007WO2007040682A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
04/12/2007WO2007040681A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007US20070082894 Pyrazine-based tubulin inhibitors
04/12/2007US20070080628 Electroluminescent devices comprising 2-(p-triphenyl)-3-phenyl-pyrazine derivatives
04/12/2007CA2624354A1 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
04/12/2007CA2624220A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
04/12/2007CA2623686A1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
04/12/2007CA2623348A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
04/12/2007CA2623045A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
04/11/2007EP1771423A1 Fungicides based on nitrogen-containing heterocycles
04/11/2007EP1771421A1 N-hydroxyamide derivatives and use thereof
04/11/2007EP1465586B1 Cosmetic compositions comprising a cyclodipeptide compound
04/11/2007EP1458689B1 Aryloxyphenyl and arylsulfanylphenyl derivatives
04/11/2007EP1351938B1 Phenyl derivatives
04/11/2007EP1015439B1 Prenyl transferase inhibitors
04/11/2007EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/10/2007US7202368 Process for the preparation of 4-(benzimidazolymethylamino) benzamidines
04/10/2007US7202361 Antitumoral ecteinascidin derivatives
04/10/2007US7202253 Cycloalkyl inhibitors of potassium channel function
04/10/2007US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders
04/10/2007US7202244 Chk-1 inhibitors
04/10/2007US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity
04/10/2007US7202092 Activated haptens useful for generating immunogens to HIV protease inhibitors; reacting indinavir sulfate in the presence of hydrogen gas and palladium catalyst to form indinavir M6
04/10/2007CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists
04/10/2007CA2204200C Phenyl alkyl ketone substituted by cyclic amine and a process for the preparation thereof
04/05/2007WO2007038243A1 Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
04/05/2007WO2007010463A3 2-amino-5-aminomethyl-phenol derivatives and agent for coloring keratin fibers comprising these derivatives
04/05/2007WO2006105304A3 Phenyl and pyridyl lta4h modulators
04/05/2007US20070078139 Phosphodiesterase 4 inhibitors
04/05/2007CA2623350A1 Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
04/04/2007EP1768955A1 Amide derivatives as inhibitors of histone deacetylase
04/04/2007CN1942436A Lysine based compounds
04/04/2007CN1939918A Production of midanping
04/04/2007CN1308297C Phenyl sulfamate derivatives
04/03/2007US7199239 Chemical compounds
04/03/2007US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists
04/03/2007US7199123 Pyrazine compounds as transforming growth factor (TGF) compounds
04/03/2007CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
04/03/2007CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
03/2007
03/29/2007WO2007035154A1 Novel n-pyrazinil-phenylsulfonamide derivatives as chemokine receptor modulators for use in the treatment of asthma
03/29/2007WO2007035153A1 Novel process for the preparation of 6-methyl-pyrazin-2-ylamine
03/29/2007WO2007035003A1 Process for producing optically active piperazine compound
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007US20070072842 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors
03/29/2007DE102005017326A1 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories
03/29/2007CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/28/2007EP1765808A1 Bisarylurea derivatives useful for inhibiting chk1
03/28/2007EP1765790A1 Azine-carboxamides as anti-cancer agent
03/28/2007EP1765778A2 N-sulfonylcarboximidamide apoptosis promoters
03/28/2007CN1938031A Biaryl substituted pyrazinones as sodium channel blockers
03/28/2007CN1935807A Aryl piperazine modified benzo [b] thiophene compound, and its preparing method and use
03/28/2007CN1935794A Method for preparing tetramethyl pyrazine
03/27/2007US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases
03/27/2007US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
03/27/2007US7196084 Cdc25 phosphatase inhibitors
03/27/2007US7195751 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis
03/27/2007CA2019580C Novel methods of treatment using ranolazine and related piperazine derivatives
03/22/2007WO2007032258A1 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same
03/22/2007US20070066822 Ionic liquids
03/22/2007US20070066658 N-{4-[4-(2-Benzylamino-ethyl)-phenoxy]-phenyl}-acetamide; eating disorders; antidiabetic, -arthritic, -epileptic, anxiolytic -lipedemic agents; anxiolytic, hypoglycemic and hypotensive agents; sexual disorders, antidepressants, hypertriglycemia, hyperlipoproteinemia, drug abuse; behavior disorders
03/22/2007US20070066600 Compounds
03/22/2007US20070066599 New compounds
03/22/2007US20070066598 Compounds
03/21/2007EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
03/21/2007EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
03/21/2007CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
03/21/2007CN1305852C Diaryl ethers as opioid receptor antagonist
03/21/2007CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
03/21/2007CN1305475C Boronic ester and acid compounds, synthesis and uses
03/20/2007US7192960 Sodium channel blockers
03/20/2007US7192959 Sodium channel blockers
03/20/2007US7192958 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
03/15/2007WO2007029806A1 Azaaromatic compounds having azafluoranthene skeletons and organic electroluminescent devices made by using the same
03/15/2007WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/15/2007US20070060757 Selective hydrogenation of amino-substituted fused bicyclic aromatic ring system, preparation of racemic amino substituted fused bicyclic ring system via nitrosation, enzymatic resolution of racemic mixture to produce (R)- and (S)-forms
03/15/2007US20070060574 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
03/15/2007US20070059553 Quinoxaline derivative, and light emitting element, light emitting device, and electronic appliance using the same
03/15/2007CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/14/2007EP1761496A2 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands
03/14/2007EP1761486A1 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes
03/14/2007EP1562936B1 Therapeutic piperazine compounds
03/14/2007CN1927844A Propionic ester compound, intermediate, preparation method and herbicide containing the same compound
1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 187